Showing results (1541-1550 of 1,745) with videos related to

Sort By:
Pageof 175
European Journal of Clinical Nutrition|February 25, 2016
Association of adherence to a Mediterranean diet with glycemic control and cardiovascular risk factors in youth with type I diabetes: the SEARCH Nutrition Ancillary StudyV W Zhong, A P Lamichhane, J L Crandell, et al.
Annals of the New York Academy of Sciences|February 5, 2021
Twenty years of pediatric diabetes surveillance: what do we know and why it mattersDana Dabelea, Katherine A Sauder, Elizabeth T Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B studyJ L Slack, D C Arthur, D Lawrence, et al.
Journal of Immigrant and Minority Health|April 7, 2012
Migration status in relation to clinical characteristics and barriers to care among youth with diabetes in the USLindsay M Jaacks, Reena Oza-Frank, Ralph D'Agostino, et al.
The Journal of Nutrition|February 25, 2023
Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or ObesityDaria Igudesman, Jamie L Crandell, Karen D Corbin, et al.
Pediatric Diabetes|August 2, 2020
Association between fear of hypoglycemia and physical activity in youth with type 1 diabetes: The SEARCH for diabetes in youth studyA J Roberts, C E Taplin, S Isom, et al.
International Journal of Oncology|October 9, 2002
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S Farag, Kellie J Archer, Krzysztof Mrózek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114Jeffrey A Meyerhardt, Joel E Tepper, Donna Niedzwiecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803Shuji Ogino, Jeffrey A Meyerhardt, Natsumi Irahara, et al.
Health & Place|February 5, 2010
Evaluating geographic variation in type 1 and type 2 diabetes mellitus incidence in youth in four US regionsAngela D Liese, Andrew Lawson, Hae-Ryoung Song, et al.
Pageof 175